Skip to main content
American Journal of Epidemiology logoLink to American Journal of Epidemiology
. 2015 Jul 15;182(5):405–416. doi: 10.1093/aje/kwv072

Dietary Pattern and Risk of Hodgkin Lymphoma in a Population-Based Case-Control Study

Mara M Epstein *, Ellen T Chang, Yawei Zhang, Teresa T Fung, Julie L Batista, Richard F Ambinder, Tongzhang Zheng, Nancy E Mueller, Brenda M Birmann
PMCID: PMC4552267  PMID: 26182945

Abstract

Classic Hodgkin lymphoma (cHL) has few known modifiable risk factors, and the relationship between diet and cHL risk is unclear. We performed the first investigation of an association between dietary pattern and cHL risk in 435 cHL cases and 563 population-based controls from Massachusetts and Connecticut (1997–2000) who completed baseline diet questionnaires. We identified 4 major dietary patterns (“vegetable,” “high meat,” “fruit/low-fat dairy,” “desserts/sweets”) using principal components analysis. We computed multivariable odds ratios and 95% confidence intervals for associations of dietary pattern score (quartiles) with younger-adult (age <50 years), older-adult (age ≥50 years), and overall cHL risk. Secondary analyses examined associations by histological subtype and tumor Epstein-Barr virus (EBV) status. A diet high in desserts/sweets was associated with younger-adult (odds ratio(quartile 4 vs. quartile 1) = 1.60, 95% confidence interval: 1.05, 2.45; Ptrend = 0.008) and EBV-negative, younger-adult (odds ratio = 2.11, 95% confidence interval: 1.31, 3.41; Ptrend = 0.007) cHL risk. A high meat diet was associated with older-adult (odds ratio = 3.34, 95% confidence interval: 1.02, 10.91; Ptrend = 0.04) and EBV-negative, older-adult (odds ratio = 4.64, 95% confidence interval: 1.03, 20.86; Ptrend = 0.04) cHL risk. Other dietary patterns were not clearly associated with cHL. We report the first evidence for a role of dietary pattern in cHL etiology. Diets featuring high intake of meat or desserts and sweets may increase cHL risk.

Keywords: case-control study, diet, Hodgkin lymphoma, principal components analysis


Classic Hodgkin lymphoma (cHL) is a relatively rare cancer with a poorly understood etiology. The epidemiology of cHL is noteworthy for a bimodal age incidence curve in developed countries, with incidence rates peaking in young adulthood (age 15–34 years) and in older adulthood (age ≥50 years) (1, 2). Known risk factors for cHL are largely unmodifiable and include age, sex, a family history of cHL or non-Hodgkin lymphoma, having a compromised immune system, and history of Epstein-Barr virus (EBV) infection. Personal history of infectious mononucleosis, which is often a manifestation of primary EBV infection, has been associated with an elevated risk of developing EBV-positive cHL, as have childhood social environment factors that influence age at first exposure to EBV, such as sibship size, birth order, and nursery school attendance (36). Serological studies suggest that severe/chronic EBV infection is associated with cHL risk, particularly with EBV-positive cHL independent of infectious mononucleosis (7, 8). Observations that the distributions of EBV-positive tumors and cHL histological subtypes vary by age group suggest age-related heterogeneity in the role of EBV and other risk factors in cHL etiology (911).

A diagnosis of cHL is pathologically confirmed by the presence of malignant Reed-Sternberg cells in affected tissue. The microenvironment of Reed-Sternberg cells, which originate from B lymphocytes, is rich in reactive inflammatory cells and suggests that chronic inflammation may play a role in cHL pathogenesis, possibly in conjunction with EBV infection (1217). Of note, numerous inflammatory mediators have been identified in Reed-Sternberg cells and Hodgkin lymphoma (HL)-derived cell lines and have been associated with HL risk in human populations (13, 15, 16, 18, 19). It is therefore plausible that modifiable factors that disrupt or modulate the immune system may be associated with cHL risk. Consistent with that hypothesis, we previously observed a 40% decreased risk of cHL in association with regular use of aspirin (20).

Of interest, specific dietary patterns have been associated with levels of inflammatory biomarkers (21). For example, diets rich in fruits, vegetables, and whole grains have been associated with lower levels of proinflammatory markers (2225). In contrast, a “Western” style diet high in fat, refined grains, red and processed meats, and oils was associated with higher levels of inflammatory markers in the same populations and with inflammation-related chronic diseases (2231).

Few previous studies have examined associations between dietary factors and cHL risk (3239). These studies focused largely on individual food items or nutrients and reported inconsistent results. To our knowledge, no study has yet examined an association between dietary pattern and the risk of cHL. We undertook the present population-based case-control analysis to evaluate whether dietary patterns influence the risk of cHL in younger or older adults.

METHODS

Study population

Cases of incident HL were recruited from the greater Boston metropolitan area of Massachusetts and the state of Connecticut from August 1, 1997, to December 31, 2000. Eligible patients were aged 15–79 years, living within the target geographical area and without human immunodeficiency virus (HIV) infection at diagnosis. Cases were identified by using the rapid case ascertainment systems of Harvard and Yale universities with additional support from the Massachusetts and Connecticut state tumor registries. There were 677 eligible cases invited to participate in the study, and 84% (n = 567) consented (32). Certain data used in this study were obtained from the Connecticut Tumor Registry located in the Connecticut Department of Public Health.

Population-based controls were frequency matched to cases by age (within 5 years), sex, and state of residence (Massachusetts or Connecticut) and did not have a personal history of HL. In greater Boston, controls were identified through the “Town Books,” annual records documenting all citizens aged ≥17 years, which are 90% complete (40). Of 720 invited controls in Massachusetts, 51% (n = 367) consented. In Connecticut, 450 eligible controls aged 18–65 years were identified by random-digit dialing, and 61% (n = 276) consented. Of 69 eligible controls in Connecticut aged 66–79 years identified through the Health Care Financing Administration (Medicare), 52% (n = 36) consented to participate (32).

The original research protocol was approved by the institutional review boards of the Harvard School of Public Health, Yale University School of Medicine, Johns Hopkins University School of Medicine, all participating hospitals, the Massachusetts Cancer Registry, and the Connecticut Tumor Registry in the Connecticut Department of Public Health (4, 20, 32). The present analysis of nonidentifiable study data was deemed exempt by the Harvard School of Public Health Human Subjects Committee.

Histopathology

Study pathologists reviewed all available pathology material to confirm an HL diagnosis (4, 4143). When possible, cHL cases were further subtyped as nodular sclerosis, mixed cellularity, lymphocyte-deleted cHL, or lymphocyte-rich cHL. Sixteen cases with nodular lymphocyte-predominant subtype HL were excluded from the analysis, as this subtype is considered biologically and clinically distinct from cHL. Tumor tissue was analyzed for EBV through in situ hybridization for EBV-encoded RNA transcripts and/or immunohistochemistry to detect the viral latency membrane protein in Reed-Sternberg cells (41, 44, 45). A tumor was considered positive for EBV if at least 1 assay was positive, and negative otherwise (46).

Data collection

Lifestyle information was collected through a structured telephone interview for 97% of study participants, while 3% completed an abbreviated mailed study questionnaire. Additionally, 511 cases (93%) and 648 controls (95%) completed a validated, semiquantitative food frequency questionnaire (FFQ) to assess average consumption of 61 food and beverage items, plus vitamin and mineral supplements, over the year prior to enrollment (47). Participants reported the average frequency of consumption for each food according to commonly used units or portion sizes, which were then converted into standard servings per day. Participants were excluded from the present analysis if they left ≥3 FFQ items blank or reported a total energy intake >3 standard deviations from the sex-specific mean on the natural log scale (n = 77).

After exclusions, we had complete FFQ data on 881 participants. An additional 183 study participants had missing data on only 1 or 2 food items. To avoid unnecessarily reducing statistical power, we imputed a value of 0 servings per day for the 43 foods for which ≥20% of the remaining study population reported 0 servings per day (Web Appendix 1 available at http://aje.oxfordjournals.org/), as missing values for infrequently consumed foods are likely to indicate 0 consumption (48, 49). The cutoff was based on an evaluation of the distribution of missing and reported 0 intake, and changes in the cutoff did not meaningfully affect the results. Missing values on foods for which <20% of the population reported 0 servings per day were retained as missing, and these individuals were excluded from the study population (n = 66). The dietary pattern analysis thus included 435 cases and 563 controls.

Dietary patterns

To identify dietary patterns common to the study population, we conducted a principal components analysis of the 61 food and beverage items included on the FFQ, followed by a varimax orthogonal rotation to improve interpretability and minimize correlation between components. The number of principal components (i.e., eigenvectors) retained in the analysis was determined graphically using the scree test, which plotted the eigenvalues (i.e., the amount of total variance explained by a principal component) by each principal component (5052). We retained 4 principal components following this assessment, each representing a separate, uncorrelated dietary pattern. Dietary patterns were ranked according to eigenvalue and described through identification of the major foods contributing to the pattern based on each food item's factor loading coefficient. As these variables were not normally distributed, we categorized the scores for each dietary pattern into quartiles. We found similar dietary patterns when the principal components analysis was conducted among the controls only and among cases and controls together; therefore, we retained patterns derived from both cases and controls because of greater stability (5356).

Statistical analysis

Multivariable unconditional logistic regression models were used to estimate odds ratios and 95% confidence intervals for the association between quartile of a given dietary pattern (lowest quartile as the reference group) and cHL risk. Linear trend across quartiles was assessed in multivariable models by modeling the median values of the quartiles as a semicontinuous variable. All tests of statistical significance were 2 sided. Multivariable models were adjusted for the matching factors, plus total daily caloric intake (kcal/day), body mass index expressed as weight (kg)/height (m)2 (<25, 25–29.9, ≥30), and potential confounders previously found to be associated with overall cHL risk: race/ethnicity (non-Hispanic white, other/missing), nursery school/day-care attendance for ≥1 year (yes, no/did not attend/missing), history of smoking ≥10 lifetime packs of cigarettes (yes, no), education (less than high school, high school, more than high school), number of siblings (0, 1, 2, 3, 4, ≥5), alcohol intake (drinker, nondrinker), regular aspirin use (≥2 regular-strength tablets/week; yes, no) and regular acetaminophen use (≥2 regular-strength tablets/week; yes, no). The primary analysis stratified cHL models by age group at diagnosis (<50 vs. ≥50) to explore potential heterogeneity in the associations of dietary patterns with younger- or older-adult cHL. Five controls missing data on smoking status (n = 1) or number of siblings (n = 4) were dropped from multivariable models, as separate categories for missing data introduced instability to the models.

Because the distributions of EBV-positive tumors and cHL histological subtypes suggest age-related heterogeneity in the role of cHL risk factors, we conducted secondary analyses to examine the association of dietary pattern with cHL risk separately by tumor EBV status (positive, negative) or histological subtype (mixed cellularity, nodular sclerosing). Age-stratified models for tumor EBV status limited covariable adjustment to matching factors, total caloric intake, and body mass index, while models for older-adult mixed cellularity subtype were not adjusted for nursery school attendance because of sparse categories. All analyses were conducted by using SAS, version 9.2, statistical software (SAS Institute, Inc., Cary, North Carolina).

RESULTS

Of the 435 cases in the final analysis, 83% were aged <50 years and 17% were aged ≥50 years at diagnosis; 68% of cases were diagnosed with nodular sclerosing cHL, and 17% of cases had EBV-positive tumors (Table 1). The study population was largely Caucasian and highly educated.

Table 1.

Descriptive Characteristics of the Study Population, a Case-Control Study of Hodgkin Lymphoma in Connecticut and Massachusetts, 1997–2000

Characteristic Cases (n = 435)
Controls
(n = 563)
No. % No. %
Sex
 Male 220 51 306 54
 Female 215 49 257 46
State of residence
 Massachusetts 242 56 315 56
 Connecticut 193 44 248 44
Age, yearsa
 <50 361 83 451 80
 ≥50 74 17 112 20
Ethnicity
 Caucasian 403 93 493 88
 Non-Caucasian/missing 32 7 70 12
Body mass indexb
 <25 232 53 264 47
 25–29.9 135 31 199 35
 ≥30 68 16 100 18
Smoked ≥10 packs of cigarettes in lifetime
 Yes 214 49 250 44
 No 221 51 312 55
 Missing 0 0 1 0.2
Day care or nursery school
 Attended for ≥1 year 48 11 89 16
 Attended for <1 year 89 20 107 19
 Did not attend/missingc 298 69 367 65
Education
 Less than high school 34 8 36 6
 Completed high school 113 26 130 23
 College or higher 288 66 396 70
Number of siblings
 0 26 6 37 7
 1–2 248 57 299 53
 3–4 114 26 156 28
 ≥5 47 11 67 12
 Unknown 0 0 4 1
Average aspirin use during the past 5 years
 ≥2 tablets per week 53 12 96 17
 <2 tablets per week 371 85 440 78
 Missing 11 3 27 5
Average acetaminophen use during the past 5 years
 ≥2 tablets per week 110 25 94 17
 <2 tablets per week 312 72 438 78
 Missing 13 3 31 5
Diagnosed with mononucleosis
 Yes 58 13 81 14
 No 368 85 478 85
 Unknown 9 2 4 1
Alcohol intaked
 Nondrinker 151 35 155 28
 Drinker 284 65 408 72
Total caloric intakee,f 1,607 (442–4,119) 1,604 (433–4,398)
Histological type
 Nodular sclerosing 295 68
 Multiple cellularity 51 12
 Other/undefined 89 20
Tumor EBV status
 Positive 73 17
 Negative 255 59
 Unknown 107 24

Abbreviation: EBV, Epstein-Barr virus.

a Age at diagnosis among cases and age at study entry among controls.

b Expressed as weight (kg)/height (m)2.

c Unable to differentiate between participants who did not attend day care or nursery school and those missing this information.

d Alcohol intake as reported on food frequency questionnaire.

e Total caloric intake reported as the mean and range of values in kcal/day.

f Values are expressed as mean (range).

The principal components analysis identified 4 distinct dietary patterns. The most prominent dietary pattern (i.e., the pattern that explained the greatest amount of total variance) was characterized by high intake of vegetables (eigenvalue: 4.6; 7.6% of total variance), with the highest positive loading factors observed for broccoli, cabbage/cauliflower, cooked spinach/collard greens, and string beans. The second most prominent dietary pattern represented a high meat diet (eigenvalue: 4.1; 6.7% of total variance), with high positive loading factors observed for hamburger, bacon, and beef, pork, or lamb meat. Other factors moderately correlated with the high meat pattern included refined or complex carbohydrates (white bread, potatoes) and sugar-sweetened beverages (Web Table 1). The third dietary pattern (eigenvalue: 2.1; 3.4% of total variance) featured high loading factors for fruits (fresh apples/pears, oranges, other fruit), as well as low-fat dairy products (yogurt, cheese). The fourth dietary pattern (eigenvalue: 1.8; 3.0% of total variance) was characterized by high intake of desserts and sweets (ready-made pie, ready-made cake, home-baked pie, ice cream). Together, the 4 dietary patterns accounted for 20.7% of the variability in the original dietary variables. Additional details on each dietary pattern are in Web Table 1.

The magnitude of most observed associations between dietary pattern and cHL risk did not change notably between univariable and multivariable models (Table 2). The risk of younger-adult cHL was increased among individuals with a dietary pattern high in desserts and sweets (multivariable odds ratio(quartile 4 vs. quartile 1) = 1.60, 95% confidence interval: 1.05, 2.45; Ptrend = 0.01), whereas the risk of older-adult cHL was not associated with this dietary pattern (Ptrend = 0.67). In contrast, the risk of older-adult cHL was significantly increased among individuals consuming a high meat dietary pattern (odds ratio = 3.34, 95% confidence interval: 1.02, 10.91; Ptrend = 0.04), but this dietary pattern was not associated with younger-adult cHL (Ptrend = 0.85). The dietary pattern high in fruit and low-fat dairy intake and the dietary pattern high in vegetable intake were not significantly associated with risk of overall, younger-adult, or older-adult cHL.

Table 2.

Associations Between Dietary Pattern and Risk of Classic Hodgkin Lymphoma, Overall and by Age Group, Connecticut and Massachusetts, 1997–2000

cHL by Age Group and Quartile Univariable
Multivariablea
Multivariableb
No. of Cases No. of Controls Odds Ratios 95% CI No. of Cases No. of Controls Odds Ratios 95% CI No. of Cases No. of Controls Odds Ratios 95% CI
High Vegetable Dietary Pattern
Overall cHL
 Quartile 1 118 131 1.00 Referent 118 131 1.00 Referent 118 129 1.00 Referent
 Quartile 2 113 137 0.92 0.64, 1.30 113 137 0.94 0.66, 1.34 113 137 0.98 0.67, 1.41
 Quartile 3 107 143 0.83 0.58, 1.18 107 143 0.85 0.59, 1.22 107 141 0.87 0.60, 1.27
 Quartile 4 97 152 0.71 0.50, 1.01 97 152 0.73 0.50, 1.07 97 151 0.78 0.52, 1.16
  Ptrendc 0.05 0.09 0.19
Age <50 yearsd
 Quartile 1 108 119 1.00 Referent 108 119 1.00 Referent 108 117 1.00 Referent
 Quartile 2 97 115 0.93 0.64, 1.35 97 115 0.93 0.64, 1.36 97 115 0.93 0.63, 1.38
 Quartile 3 84 107 0.87 0.59, 1.27 84 107 0.86 0.59, 1.27 84 106 0.85 0.57, 1.27
 Quartile 4 72 110 0.72 0.49, 1.07 72 110 0.74 0.49, 1.10 72 109 0.76 0.49, 1.16
  Ptrendc 0.10 0.13 0.17
Age ≥50 years
 Quartile 1 10 12 1.00 Referent 10 12 1.00 Referent 10 12 1.00 Referent
 Quartile 2 16 22 0.87 0.30, 2.51 16 22 0.94 0.32, 2.81 16 22 1.12 0.35, 3.51
 Quartile 3 23 36 0.77 0.29, 2.06 23 36 0.68 0.24, 1.90 23 35 0.72 0.25, 2.11
 Quartile 4 25 42 0.71 0.27, 1.89 25 42 0.51 0.17, 1.49 25 42 0.68 0.22, 2.13
  Ptrendc 0.46 0.14 0.34
Western-Style Dietary Pattern
Overall cHL
 Quartile 1 108 141 1.00 Referent 108 141 1.00 Referent 108 139 1.00 Referent
 Quartile 2 109 141 1.01 0.71, 1.44 109 141 1.09 0.76, 1.57 109 141 1.09 0.75, 1.59
 Quartile 3 104 146 0.93 0.65, 1.33 104 146 1.06 0.72, 1.56 104 144 1.06 0.72, 1.59
 Quartile 4 114 135 1.10 0.77, 1.57 114 135 1.38 0.87, 2.20 114 134 1.39 0.86, 2.26
  Ptrendc 0.71 0.25 0.26
Age <50 yearsd
 Quartile 1 91 107 1.00 Referent 91 107 1.00 Referent 91 105 1.00 Referent
 Quartile 2 88 105 0.99 0.66, 1.47 88 105 1.03 0.68, 1.55 88 105 1.02 0.67, 1.56
 Quartile 3 86 122 0.83 0.56, 1.23 86 122 0.90 0.58, 1.38 86 121 0.89 0.57, 1.39
 Quartile 4 96 117 0.97 0.65, 1.42 96 117 1.11 0.66, 1.86 96 116 1.08 0.63, 1.87
  Ptrendc 0.67 0.92 0.99
Age ≥50 years
 Quartile 1 17 34 1.00 Referent 17 34 1.00 Referent 17 34 1.00 Referent
 Quartile 2 21 36 1.17 0.53, 2.58 21 36 1.20 0.52, 2.76 21 36 1.14 0.48, 2.72
 Quartile 3 18 24 1.50 0.65, 3.49 18 24 1.79 0.70, 4.54 18 23 1.78 0.67, 4.74
 Quartile 4 18 18 2.00 0.83, 4.80 18 18 2.93 0.97, 8.86 18 18 3.34 1.02, 10.91
  Ptrendc 0.10 0.05 0.04
Fruit/Low-Fat Dairy Dietary Pattern
Overall cHL
 Quartile 1 118 131 1.00 Referent 118 131 1.00 Referent 118 129 1.00 Referent
 Quartile 2 103 147 0.78 0.55, 1.11 103 147 0.75 0.52, 1.07 103 147 0.70 0.48, 1.01
 Quartile 3 108 142 0.84 0.59, 1.20 108 142 0.78 0.54, 1.13 108 140 0.80 0.55, 1.18
 Quartile 4 106 143 0.82 0.58, 1.17 106 143 0.74 0.49, 1.11 106 142 0.70 0.45, 1.07
  Ptrendc 0.38 0.17 0.18
Age <50 yearsd
 Quartile 1 89 103 1.00 Referent 89 103 1.00 Referent 89 101 1.00 Referent
 Quartile 2 90 114 0.91 0.62, 1.36 90 114 0.90 0.60, 1.34 90 114 0.86 0.57, 1.30
 Quartile 3 89 110 0.94 0.63, 1.39 89 110 0.89 0.59, 1.36 89 109 0.94 0.61, 1.46
 Quartile 4 93 124 0.87 0.59, 1.28 93 124 0.85 0.54, 1.33 93 123 0.83 0.51, 1.34
  Ptrendc 0.53 0.49 0.55
Age ≥50 years
 Quartile 1 29 28 1.00 Referent 29 28 1.00 Referent 29 28 1.00 Referent
 Quartile 2 13 33 0.38 0.17, 0.87 13 33 0.33 0.14, 0.78 13 33 0.24 0.10, 0.62
 Quartile 3 19 32 0.57 0.27, 1.24 19 32 0.53 0.23, 1.18 19 31 0.43 0.18, 1.04
 Quartile 4 13 19 0.66 0.28, 1.59 13 19 0.50 0.19, 1.33 13 19 0.42 0.15, 1.19
  Ptrendc 0.33 0.17 0.13
Desserts/Sweets Dietary Pattern
Overall cHL
 Quartile 1 92 157 1.00 Referent 92 157 1.00 Referent 92 155 1.00 Referent
 Quartile 2 106 144 1.26 0.88, 1.80 106 144 1.21 0.84, 1.74 106 144 1.16 0.80, 1.69
 Quartile 3 120 130 1.58 1.10, 2.25 120 130 1.56 1.09, 2.24 120 128 1.49 1.03, 2.17
 Quartile 4 117 132 1.51 1.06, 2.16 117 132 1.59 1.10, 2.30 117 131 1.50 1.02, 2.21
  Ptrendc 0.01 0.005 0.02
Age <50 yearsd
 Quartile 1 80 135 1.00 Referent 80 135 1.00 Referent 80 133 1.00 Referent
 Quartile 2 89 125 1.20 0.82, 1.77 89 125 1.16 0.79, 1.72 89 125 1.10 0.73, 1.65
 Quartile 3 101 97 1.76 1.19, 2.60 101 97 1.73 1.17, 2.57 101 96 1.63 1.08, 2.46
 Quartile 4 91 94 1.63 1.10, 2.44 91 94 1.69 1.12, 2.54 91 93 1.60 1.05, 2.45
  Ptrendc 0.004 0.002 0.008
Age ≥50 years
 Quartile 1 12 22 1.00 Referent 12 22 1.00 Referent 12 22 1.00 Referent
 Quartile 2 17 19 1.64 0.63, 4.29 17 19 1.33 0.49, 3.59 17 19 1.43 0.48, 4.23
 Quartile 3 19 33 1.06 0.43, 2.60 19 33 0.90 0.35, 2.26 19 32 0.78 0.28, 2.21
 Quartile 4 26 38 1.25 0.53, 2.97 26 38 1.07 0.43, 2.70 26 38 0.94 0.34, 2.61
  Ptrendc 0.90 0.87 0.60

Abbreviations: cHL, classic Hodgkin lymphoma; CI, confidence interval.

a Logistic regression models adjusted for sex, age (overall only), state of residence, total daily caloric intake, and body mass index.

b Logistic regression models additionally adjusted for race, alcohol intake, smoking, education, attended nursery school >1 year, number of siblings, regular aspirin use, and regular acetaminophen use.

c Test for trend across quartiles from logistic regression model, modeling the median of each quartile as a semicontinuous variable.

d Age defined as age at diagnosis (years) for cases and age at study entry for controls.

When cHL risk was examined jointly by age group and tumor EBV status, younger adults consuming a diet rich in desserts and sweets had more than a 2-fold increased risk of EBV-negative cHL (multivariable odds ratio(quartile 4 vs. quartile 1) = 2.11, 95% confidence interval: 1.31, 3.41; Ptrend = 0.001) (Table 3). Among the markedly smaller stratum of older adults, we observed a positive association between the high meat dietary pattern and tumor EBV-negative cHL that appeared strong but imprecise (odds ratio = 4.64, 95% confidence interval: 1.03, 20.86; Ptrend = 0.04) among 35 cases. There were no significant associations between dietary pattern and tumor EBV-positive cHL in either age group or overall (Web Table 2).

Table 3.

Association Between Dietary Pattern and Risk of Classic Hodgkin Lymphoma by Tumor Epstein-Barr Virus Status, Overall and by Age Group for Selected Dietary Patterns, Connecticut and Massachusetts, 1997–2000

cHL by Age Group and Quartile High Meat Dietary Pattern
Desserts/Sweets Dietary Pattern
No. of
Cases
No. of
Controls
Odds
Ratioa
95% CI No. of
Cases
No. of
Controls
Odds
Ratioa
95% CI
EBV-Positive Tumors
Overall
 Quartile 1 17 141 1.00 Referent 19 157 1.00 Referent
 Quartile 2 15 141 0.91 0.43, 1.94 22 144 1.31 0.67, 2.55
 Quartile 3 16 146 0.99 0.46, 2.14 15 130 0.96 0.47, 1.98
 Quartile 4 25 135 1.74 0.73, 4.17 17 132 1.06 0.52, 2.16
  Ptrendb 0.16 0.93
Age <50 yearsc
 Quartile 1 12 107 1.00 Referent 16 135 1.00 Referent
 Quartile 2 10 105 0.92 0.37, 2.30 15 125 1.04 0.49, 2.23
 Quartile 3 10 122 0.84 0.33, 2.18 13 97 1.16 0.53, 2.55
 Quartile 4 22 117 2.33 0.83, 6.52 10 94 0.87 0.37, 2.04
  Ptrendb 0.07 0.79
Age ≥50 years
 Quartile 1 5 34 1.00 Referent 22 1.00 Referent
 Quartile 2 5 36 0.68 0.16, 2.85 7 19 2.85 0.60, 13.60
 Quartile 3 6 24 1.33 0.32, 5.60 2 33 0.42 0.06, 2.80
 Quartile 4 3 18 0.68 0.10, 4.50 7 38 1.27 0.27, 5.94
  Ptrendb 0.91 0.71
EBV-Negative Tumors
Overall
 Quartile 1 59 141 1.00 Referent 52 157 1.00 Referent
 Quartile 2 67 141 1.23 0.79, 1.89 62 144 1.24 0.80, 1.92
 Quartile 3 65 146 1.24 0.78, 1.96 67 130 1.53 0.99, 2.36
 Quartile 4 64 135 1.47 0.84, 2.57 74 132 1.77 1.15, 2.74
  Ptrendb 0.21 0.008
Age <50 yearsc
 Quartile 1 53 107 1.00 Referent 45 135 1.00 Referent
 Quartile 2 56 105 1.14 0.70, 1.83 54 125 1.23 0.77, 1.97
 Quartile 3 56 122 1.03 0.62, 1.70 59 97 1.80 1.13, 2.88
 Quartile 4 55 117 1.15 0.62, 2.11 62 94 2.11 1.31, 3.41
  Ptrendb 0.77 0.001
Age ≥50 years
 Quartile 1 6 34 1.00 Referent 7 22 1.00 Referent
 Quartile 2 11 36 1.81 0.57, 5.74 8 19 1.00 0.29, 3.48
 Quartile 3 9 24 2.67 0.73, 9.73 8 33 0.67 0.21, 2.18
 Quartile 4 9 18 4.64 1.03, 20.86 12 38 0.77 0.24, 2.46
  Ptrendb 0.04 0.60

Abbreviations: CI, confidence interval; EBV, Epstein-Barr virus.

a All logistic regression models adjusted for sex, state of residence, total caloric intake, and body mass index.

b Test for trend from logistic regression model, modeling the median of each quartile as a semicontinuous variable.

c Age defined as the age at diagnosis for cases and the age at study entry for controls.

In histological subtype-specific analyses, consuming a diet high in desserts and sweets was associated with a nonsignificant 43% increased risk of nodular sclerosing cHL overall (n = 295 cases) (Table 4). Odds ratios for the association between a diet high in desserts and sweets and nodular sclerosing cHL risk were similar in magnitude for younger- and older-adult nodular sclerosing cHL. The analysis of 51 mixed cellularity cHL cases yielded a suggestive, nonsignificant inverse association with the dietary pattern high in fruit and low-fat dairy intake. Because of small numbers, we were unable to cross-classify any case group by EBV status and histological subtype.

Table 4.

Associations Between Dietary Pattern and Classic Hodgkin Lymphoma by Histological Subtype, Overall and by Age Group, Connecticut and Massachusetts, 1997–2000

cHL by Age Group and Quartile Diet Pattern
High Vegetable
Western Style
Fruit/Low-Fat Dairy
Desserts/Sweets
No. of Cases No. of Controls Odds Ratio 95% CI No. of Cases No. of Controls Odds Ratio 95% CI No. of Cases No. of Controls Odds Ratio 95% CI No. of Cases No. of Controls Odds Ratio 95% CI
Nodular Sclerosinga
Overallb
 Quartile 1 84 131 1.0 Referent 76 141 1.0 Referent 74 131 1.0 Referent 60 157 1.0 Referent
 Quartile 2 74 137 0.88 0.58, 1.34 76 141 1.07 0.70, 1.62 78 147 0.80 0.53, 1.21 82 144 1.34 0.88, 2.04
 Quartile 3 74 143 0.83 0.55, 1.26 68 146 1.05 0.67, 1.65 73 142 0.77 0.50, 1.19 74 130 1.29 0.84, 1.98
 Quartile 4 63 152 0.69 0.45, 1.06 75 135 1.39 0.81, 2.41 70 143 0.69 0.42, 1.13 79 132 1.43 0.93, 2.21
  Ptrendc 0.07 0.24 0.15 0.16
Age <50 yearsd
 Quartile 1 81 119 1.0 Referent 68 107 1.0 Referent 62 103 1.0 Referent 56 135 1.0 Referent
 Quartile 2 68 115 0.90 0.58, 1.40 65 105 1.04 0.65, 1.66 70 114 0.90 0.57, 1.42 73 125 1.25 0.80, 1.94
 Quartile 3 60 107 0.88 0.55, 1.39 63 122 0.93 0.57, 1.52 64 110 0.90 0.55, 1.45 67 97 1.48 0.93, 2.35
 Quartile 4 51 110 0.76 0.47, 1.25 64 117 1.06 0.58, 1.94 64 124 0.76 0.45, 1.30 64 94 1.66 1.03, 2.69
  Ptrendc 0.24 0.92 0.33 0.04
Age ≥50 years
 Quartile 1 3 12 1.0 Referent 8 34 1.0 Referent 12 28 1.0 Referent 4 22 1.0 Referent
 Quartile 2 6 22 1.51 0.25, 9.16 11 36 1.04 0.32, 3.40 8 33 0.26 0.07, 0.94 9 19 3.70 0.69, 19.86
 Quartile 3 14 36 1.63 0.32, 8.22 5 24 0.95 0.21, 4.35 9 32 0.40 0.12, 1.32 7 33 0.94 0.18, 5.03
 Quartile 4 12 42 1.22 0.22, 6.78 11 18 3.13 0.62, 15.83 6 19 0.41 0.10, 1.72 15 38 1.58 0.32, 7.75
  Ptrendc 0.99 0.15 0.28 0.93
Mixed Cellularity
Overall
 Quartile 1 11 131 1.0 Referent 7 141 1.0 Referent 23 131 1.0 Referent 15 157 1.0 Referent
 Quartile 2 14 137 0.91 0.38, 2.17 13 141 1.88 0.70, 5.04 8 147 0.35 0.14, 0.83 4 144 0.33 0.11, 1.06
 Quartile 3 14 143 0.95 0.40, 2.26 13 146 1.77 0.64, 4.92 11 142 0.56 0.25, 1.28 19 130 1.91 0.89, 4.10
 Quartile 4 12 152 0.69 0.28, 1.73 18 135 2.66 0.83, 8.53 9 143 0.38 0.15, 1.01 13 132 1.29 0.56, 2.98
  Ptrendc 0.43 0.15 0.07 0.20
Age <50 yearsd
 Quartile 1 7 119 1.0 Referent 4 107 1.0 Referent 12 103 1.0 Referent 10 135 1.0 Referent
 Quartile 2 11 115 1.37 0.48, 3.94 7 105 1.10 0.29, 4.21 5 114 0.51 0.16, 1.59 3 125 0.37 0.09, 1.47
 Quartile 3 9 107 1.31 0.42, 4.04 8 122 0.98 0.25, 3.80 8 110 0.98 0.34, 2.82 12 97 2.72 1.00, 7.40
 Quartile 4 6 110 0.84 0.24, 2.95 14 117 1.30 0.29, 5.79 8 124 0.61 0.19, 2.02 8 94 1.69 0.57, 4.99
  Ptrendc 0.68 0.72 0.54 0.14
Age ≥50 yearse
 Quartile 1 4 12 1.0 Referent 3 34 1.0 Referent 11 28 1.0 Referent 5 22 1.0 Referent
 Quartile 2 3 22 0.20 0.03, 1.43 6 36 3.59 0.63, 20.43 3 33 0.17 0.04, 0.85 1 19 0.14 0.01, 1.70
 Quartile 3 5 36 0.27 0.05, 1.50 5 24 4.57 0.69, 30.22 3 32 0.27 0.05, 1.31 7 33 0.89 0.18, 4.37
 Quartile 4 6 42 0.19 0.03, 1.22 4 18 6.78 0.72, 63.88 1 19 0.07 0.01, 0.81 5 38 0.72 0.13, 3.90
  Ptrendc 0.20 0.12 0.02 0.91

Abbreviation: CI, confidence interval.

a Histological subtype determined by pathology review.

b Logistic regression models adjusted for sex, state of residence, total daily caloric intake, body mass index, race, alcohol intake, smoking, education, attended nursery school >1 year, number of siblings, regular aspirin use, and regular acetaminophen use.

c Test for trend from logistic regression model, modeling the median of each quartile as a semicontinuous variable.

d Age defined as the age at diagnosis for cases and the age at study entry for controls.

e Model for older-adult mixed cellularity subtype adjusted for sex, state of residence, total daily caloric intake, body mass index, race, alcohol intake, smoking, education, number of siblings, regular aspirin use, and regular acetaminophen use.

DISCUSSION

In this population-based case-control study, we observed positive associations between a diet high in desserts and sweets and cHL risk, particularly with total and EBV-negative younger-adult cHL and with nodular sclerosing cHL. We also observed positive associations between a high meat dietary pattern and risk of older-adult cHL, and particularly EBV-negative older-adult cHL, although power was limited in some of the jointly classified strata. A suggestive, albeit imprecise inverse association between a diet characterized by high intake of fruit and low-fat dairy products and mixed cellularity cHL risk warrants further study. We did not observe any statistically significant associations between cHL risk and a dietary pattern high in vegetable intake.

In this analysis, we characterized dietary patterns through a principal components analysis, which agnostically defined dietary patterns that best captured the food consumption habits reported in the study FFQ and accounted for the variability among participants' diet. The 4 selected dietary patterns together accounted for 20.7% of the total variability in the original diet variables, reflecting the considerable variability of individual diets. The amount of total explained variability is consistent with other epidemiologic studies of dietary patterns derived from principal components analysis, which explained between 19% and 24% of variability in those study populations (23, 29, 57).

We observed several significant positive associations between cHL risk and a diet high in desserts and sweets, especially among younger adults. An experimental study in overweight adults suggested that a high-sucrose diet may increase levels of the inflammatory marker C-reactive protein (58). However, a recent 6-month randomized trial of high glycemic index diet, low glycemic index diet, and low-fat diet among overweight and obese adults observed no significant changes in inflammatory or metabolic risk biomarkers among the diet groups (59). In contrast, other studies have suggested that low glycemic load diets may be associated with reduced levels of inflammatory markers including C-reactive protein (60, 61). We also observed significant positive associations between cHL risk and a high meat dietary pattern, in particular among older adults. Previous studies have linked a diet high in fat, refined grains, red and processed meats, and oils to higher levels of proinflammatory biomarkers, including C-reactive protein and interleukin 6 (2225), which have also been associated with HL risk (14, 18, 62), suggesting a possible biological link between a Western-style dietary pattern and cHL risk through inflammation. An inflammation-related mechanism may underlie the observed associations between cHL risk and both the desserts/sweets and high meat dietary patterns; however, it is unclear why this mechanism would vary between age groups.

Existing studies of diet and HL risk have yielded inconsistent results, although some elements of a Western-style diet have been associated previously with an increased HL risk. Previous analyses of cHL and diet in our study population showed a significant positive association between EBV-negative cHL and multivitamin, supplemental vitamin B6, and supplemental vitamin B12 use (32); a significant positive association of younger-adult cHL risk with higher saturated fat intake in women; and a significant inverse association of younger-adult cHL risk with higher monounsaturated fat intake, also among women (33). An analysis of the prospective California Teachers Study cohort found a significant 2-fold increased risk of HL with high consumption of dark/whole grain bread, and no association with various phytocompounds (34). Case-control studies of dietary factors and HL risk in Italy reported suggestive inverse associations with higher intake of whole grains (36) and no association with fruit, vegetable, or red meat intake (37, 38), while higher intake of liver and ham increased HL risk (39), although case numbers were generally small. A multisite case-control study observed an increased risk of HL associated with dietary vitamin A intake in men (63).

Overall, our findings of an increased risk of EBV-negative disease related to high consumption of a diet rich in desserts and sweets (for younger adults) and meat (for older adults) suggest that diet may influence HL risk independently of EBV infection. Alternatively, any association of diet with EBV-positive cHL risk may be weak in comparison to the influences of altered host control of EBV infection and related immune dysregulation (8). This hypothesis is supported by the lack of any strong association between dietary pattern and EBV-positive disease in our study population, although numbers of EBV-positive cases were small, and statistical power was limited to detect such an association.

Although our study population was one of the largest case-control studies of HL to date, certain subgroup analyses had limited statistical power, most notably those stratified by cHL histological subtype or related to EBV-positive cHL. The effect estimates from those models are highly imprecise and must be interpreted with particular caution until confirmed in other populations. Cases may have recalled their diet habits differently from controls, leading to recall bias. In addition, as diet was recalled for the year prior to index date or diagnosis, we cannot rule out reverse causality or that the reference period did not adequately capture diet habits in the time window of greatest relevance to disease initiation or promotion (although this time period is not known). To avoid unnecessarily excluding 117 people who missed only 1 or 2 FFQ items, we imputed values of 0 servings/day for 43 foods that were generally less commonly consumed in the study population. Some of these omissions may not truly represent 0 servings/day, and thus we may have introduced a small amount of misclassification into the diet scores. Control participation rates varied slightly by state and recruitment method and were lower than among cases. However, we replaced nonparticipating Massachusetts controls with individuals from the same residential area to limit the potential for selection bias, and Chang et al. (20) demonstrated that the income distribution across census tracts of Massachusetts controls who participated was representative of the source population (33). Data to evaluate potential selection bias among Connecticut controls were not available.

Our study is the first to examine a potential association between dietary pattern and cHL risk by using a validated FFQ to retrospectively assess diet. The large study population allowed us to collect information on, and statistically adjust for, a number of potential confounding factors, including those identified in prior analyses of this study population. In addition, we conducted analyses separately by age group, tumor EBV status, and histological subtype, which may help to elucidate etiologically distinct subtypes of cHL. In conclusion, this study is the first to suggest that dietary pattern may play a role in the development of cHL, with apparent variation by age group, tumor EBV status, and possibly also by histological subtype. These results require confirmation in additional populations, including in studies with prospectively assessed dietary intake.

Supplementary Material

Web Material

ACKNOWLEDGMENTS

Author affiliations: Department of Medicine and the Meyers Primary Care Institute, University of Massachusetts Medical School, Worcester, Massachusetts (Mara M. Epstein); Health Sciences Practice, Exponent, Inc., Menlo Park, California (Ellen T. Chang); Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California (Ellen T. Chang); Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut (Yawei Zhang, Tongzhang Zheng); Department of Nutrition, Simmons College, Boston, Massachusetts (Teresa T. Fung); Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts (Teresa T. Fung); Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts (Julie L. Batista, Nancy E. Mueller); Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Julie L. Batista, Brenda M. Birmann); and Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland (Richard F. Ambinder).

This work was supported by the National Cancer Institute (grants P01 CA069266 and R01 CA149445); the American Cancer Society (grant RSG-11-020-01-CNE to B.M.B.); and the Meyers Primary Care Institute at the University of Massachusetts Medical School (funding to M.M.E.).

We appreciate the assistance of staff members at participating hospitals in Massachusetts and Connecticut and thank Judith Fine, Rajni Mehta, and Patricia Owens (Yale University Rapid Case Ascertainment and School of Medicine) and Dr. Dan Friedman (Massachusetts Cancer Registry). We also thank Dr. Edward Weir, Dr. Michael Borowitz, and Dr. Risa Mann (Johns Hopkins Medical Institutions) for conducting the pathology review; Kathryn Trainor, Patricia Morey, and Dr. Karen Pawlish (Harvard School of Public Health) for project and data management; Mary Fronk (Harvard School of Public Health) for administrative support; and Stacey Morin and Linda Post (Johns Hopkins Medical Institutions) for technical assistance at their study centers. We also thank the participating staff members at the following hospitals in Massachusetts: AtlantiCare Medical Center (Lynn), Beth Israel Deaconess Medical Center (Boston), Beverly Hospital (Beverly), Boston Medical Center (Boston), Brigham and Women's Hospital (Boston), Brockton Hospital (Brockton), Brockton VA/West Roxbury Hospital (West Roxbury), Cambridge Hospital (Cambridge), Caritas Southwood Hospital (Walpole), Carney Hospital (Dorchester), Children's Hospital Boston (Boston), Dana-Farber Cancer Institute (Boston), Deaconess Glover Memorial Hospital (Needham), Deaconess Waltham Hospital (Waltham), Emerson Hospital (Concord), Faulkner Hospital (Boston), Good Samaritan Medical Center (Brockton), Harvard Vanguard (Boston), Holy Family Hospital and Medical Center (Methuen), Jordan Hospital (Plymouth), Lahey Hitchcock Medical Center (Lexington), Lawrence General Hospital (Lawrence), Lawrence Memorial Hospital of Medford (Medford), Lowell General Hospital (Lowell), Massachusetts Eye and Ear Infirmary (Boston), Massachusetts General Hospital (Boston), Melrose-Wakefield Hospital (Melrose), MetroWest Medical Center (Framingham), Morton Hospital (Taunton), Mount Auburn Hospital (Cambridge), New England Baptist Hospital (Roxbury Crossing), New England Medical Center (Boston), Newton Wellesley Hospital (Newton), North Shore Medical Center (Salem), Norwood Hospital (Norwood), Quincy Hospital (Quincy), Saint's Memorial Hospital (Lowell), South Shore Hospital (South Weymouth), St. Elizabeth's Hospital (Brighton), Sturdy Memorial Hospital (Attleboro), University of Massachusetts Medical Center (Worcester), and Winchester Hospital (Winchester); and in Connecticut: Bridgeport Hospital (Bridgeport), Bristol Hospital (Bristol), Charlotte Hungerford Hospital (Torrington), Danbury Hospital (Danbury), Day-Kimball Hospital (Putnam), Greenwich Hospital (Greenwich), Griffin Hospital (Derby), Hartford Hospital (Hartford), Johnson Memorial Hospital (Stafford), Lawrence and Memorial Hospital (New London), Manchester Memorial Hospital (Manchester), MidState Medical Center (Meriden), Middlesex Memorial Hospital (Middletown), Milford Hospital (Milford), New Britain General Hospital (New Britain), New Milford Hospital (New Milford), Norwalk Hospital (Norwalk), Rockville General Hospital (Vernon), Sharon Hospital (Sharon), St. Francis Hospital and Medical Center (Hartford), St. Mary's Hospital (Waterbury), St. Raphael's Hospital (New Haven), St. Vincent's Medical Center (Bridgeport), Stamford Hospital (Stamford), William W. Backus Hospital (Norwich), Waterbury Hospital (Waterbury), Windham Hospital (Willimantic), and Yale-New Haven Hospital (New Haven).

The abstract from this manuscript was presented as a poster at the Society for Epidemiologic Research 46th Annual Meeting, June 20, 2013, Boston, Massachusetts (abstract 491-S).

The authors assume full responsibility for the analyses and interpretation of the data used in this study.

Conflict of interest: none declared.

REFERENCES

  • 1.MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res. 1966;266:1189–1201. [PubMed] [Google Scholar]
  • 2.Clarke CA, Glaser SL, Prehn AW. Age-specific survival after Hodgkin's disease in a population-based cohort (United States). Cancer Causes Control. 2001;129:803–812. [DOI] [PubMed] [Google Scholar]
  • 3.Hjalgrim H, Smedby KE, Rostgaard K, et al. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res. 2007;675:2382–2388. [DOI] [PubMed] [Google Scholar]
  • 4.Chang ET, Zheng T, Weir EG, et al. Childhood social environment and Hodgkin's lymphoma: new findings from a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2004;138:1361–1370. [PubMed] [Google Scholar]
  • 5.Westergaard T, Melbye M, Pedersen JB, et al. Birth order, sibship size and risk of Hodgkin's disease in children and young adults: a population-based study of 31 million person-years. Int J Cancer. 1997;726:977–981. [DOI] [PubMed] [Google Scholar]
  • 6.Hjalgrim H, Askling J, Rostgaard K, et al. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med. 2003;34914:1324–1332. [DOI] [PubMed] [Google Scholar]
  • 7.Mueller NE, Lennette ET, Dupnik K, et al. Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis. Int J Cancer. 2012;13012:2886–2891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Levin LI, Chang ET, Ambinder RF, et al. Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma. Blood. 2012;12018:3750–3755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Glaser SL, Clarke CA, Stearns CB, et al. Age variation in Hodgkin's disease risk factors in older women: evidence from a population-based case-control study. Leuk Lymphoma. 2001;425:997–1004. [DOI] [PubMed] [Google Scholar]
  • 10.Lee JH, Kim Y, Choi JW, et al. Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin's lymphoma: a meta-analysis. Arch Med Res. 2014;455:417–431. [DOI] [PubMed] [Google Scholar]
  • 11.Cozen W, Katz J, Mack TM. Risk patterns of Hodgkin's disease in Los Angeles vary by cell type. Cancer Epidemiol Biomarkers Prev. 1992;14:261–268. [PubMed] [Google Scholar]
  • 12.Bertrand KA, Chang ET, Abel GA, et al. Sunlight exposure, vitamin D, and risk of non-Hodgkin lymphoma in the Nurses’ Health Study. Cancer Causes Control. 2011;2212:1731–1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kurzrock R. Cytokine deregulation in hematological malignancies: clinical and biological implications. Clin Cancer Res. 1997;3(12 pt 2):2581–2584. [PubMed] [Google Scholar]
  • 14.Biggar RJ, Johansen JS, Smedby KE, et al. Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma. Clin Cancer Res. 2008;1421:6974–6978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Seymour JF, Talpaz M, Hagemeister FB, et al. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease. Am J Med. 1997;1021:21–28. [DOI] [PubMed] [Google Scholar]
  • 16.Vener C, Guffanti A, Pomati M, et al. Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis. Leuk Lymphoma. 2000;37(3-4):333–339. [DOI] [PubMed] [Google Scholar]
  • 17.Khan G. Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma? Exp Hematol. 2006;344:399–406. [DOI] [PubMed] [Google Scholar]
  • 18.Cozen W, Gill PS, Ingles SA, et al. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood. 2004;1038:3216–3221. [DOI] [PubMed] [Google Scholar]
  • 19.Cozen W, Gill PS, Salam MT, et al. Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma. Blood. 2008;1117:3377–3382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Chang ET, Zheng T, Weir EG, et al. Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study. J Natl Cancer Inst. 2004;964:305–315. [DOI] [PubMed] [Google Scholar]
  • 21.Barbaresko J, Koch M, Schulze MB, et al. Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review. Nutr Rev. 2013;718:511–527. [DOI] [PubMed] [Google Scholar]
  • 22.Lopez-Garcia E, Schulze MB, Fung TT, et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2004;804:1029–1035. [DOI] [PubMed] [Google Scholar]
  • 23.Esmaillzadeh A, Kimiagar M, Mehrabi Y, et al. Dietary patterns and markers of systemic inflammation among Iranian women. J Nutr. 2007;1374:992–998. [DOI] [PubMed] [Google Scholar]
  • 24.Nettleton JA, Steffen LM, Mayer-Davis EJ, et al. Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2006;836:1369–1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Julia C, Meunier N, Touvier M, et al. Dietary patterns and risk of elevated C-reactive protein concentrations 12 years later. Br J Nutr. 2013;1104:747–754. [DOI] [PubMed] [Google Scholar]
  • 26.Hu FB, Rimm EB, Stampfer MJ, et al. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000;724:912–921. [DOI] [PubMed] [Google Scholar]
  • 27.Iqbal R, Anand S, Ounpuu S, et al. Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART Study. Circulation. 2008;11819:1929–1937. [DOI] [PubMed] [Google Scholar]
  • 28.Fung TT, Willett WC, Stampfer MJ, et al. Dietary patterns and the risk of coronary heart disease in women. Arch Intern Med. 2001;16115:1857–1862. [DOI] [PubMed] [Google Scholar]
  • 29.Link LB, Canchola AJ, Bernstein L, et al. Dietary patterns and breast cancer risk in the California Teachers Study cohort. Am J Clin Nutr. 2013;986:1524–1532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Karimi Z, Jessri M, Houshiar-Rad A, et al. Dietary patterns and breast cancer risk among women. Public Health Nutr. 2014;175:1098–1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Randi G, Edefonti V, Ferraroni M, et al. Dietary patterns and the risk of colorectal cancer and adenomas. Nutr Rev. 2010;687:389–408. [DOI] [PubMed] [Google Scholar]
  • 32.Kasperzyk JL, Chang ET, Birmann BM, et al. Nutrients and genetic variation involved in one-carbon metabolism and Hodgkin lymphoma risk: a population-based case-control study. Am J Epidemiol. 2011;1747:816–827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Gao Y, Li Q, Bassig BA, et al. Subtype of dietary fat in relation to risk of Hodgkin lymphoma: a population-based case-control study in Connecticut and Massachusetts. Cancer Causes Control. 2013;243:485–494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Chang ET, Canchola AJ, Clarke CA, et al. Dietary phytocompounds and risk of lymphoid malignancies in the California Teachers Study cohort. Cancer Causes Control. 2011;222:237–249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gorini G, Stagnaro E, Fontana V, et al. Alcohol consumption and risk of Hodgkin's lymphoma and multiple myeloma: a multicentre case-control study. Ann Oncol. 2007;181:143–148. [DOI] [PubMed] [Google Scholar]
  • 36.La Vecchia C, Chatenoud L, Negri E, et al. Session: whole cereal grains, fibre and human cancer wholegrain cereals and cancer in Italy. Proc Nutr Soc. 2003;621:45–49. [DOI] [PubMed] [Google Scholar]
  • 37.Negri E, La Vecchia C, Franceschi S, et al. Vegetable and fruit consumption and cancer risk. Int J Cancer. 1991;483:350–354. [DOI] [PubMed] [Google Scholar]
  • 38.Tavani A, La Vecchia C, Gallus S, et al. Red meat intake and cancer risk: a study in Italy. Int J Cancer. 2000;863:425–428. [DOI] [PubMed] [Google Scholar]
  • 39.Tavani A, Pregnolato A, Negri E, et al. Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer. 1997;273:256–260. [DOI] [PubMed] [Google Scholar]
  • 40.Bohlke K, Harlow BL, Cramer DW, et al. Evaluation of a population roster as a source of population controls: the Massachusetts Resident Lists. Am J Epidemiol. 1999;1504:354–358. [DOI] [PubMed] [Google Scholar]
  • 41.Chang ET, Zheng T, Lennette ET, et al. Heterogeneity of risk factors and antibody profiles in Epstein-Barr virus genome-positive and -negative Hodgkin lymphoma. J Infect Dis. 2004;18912:2271–2281. [DOI] [PubMed] [Google Scholar]
  • 42.Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001. [Google Scholar]
  • 43.Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol. 2000;132:193–207. [DOI] [PubMed] [Google Scholar]
  • 44.Ambinder RF, Mann RB. Epstein-Barr-encoded RNA in situ hybridization: diagnostic applications. Hum Pathol. 1994;256:602–605. [DOI] [PubMed] [Google Scholar]
  • 45.Staal SP, Ambinder R, Beschorner WE, et al. A survey of Epstein-Barr virus DNA in lymphoid tissue. Frequent detection in Hodgkin's disease. Am J Clin Pathol. 1989;911:1–5. [DOI] [PubMed] [Google Scholar]
  • 46.Gulley ML, Glaser SL, Craig FE, et al. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol. 2002;1172:259–267. [DOI] [PubMed] [Google Scholar]
  • 47.Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;1221:51–65. [DOI] [PubMed] [Google Scholar]
  • 48.Hansson LM, Galanti MR. Diet-associated risks of disease and self-reported food consumption: how shall we treat partial nonresponse in a food frequency questionnaire? Nutr Cancer. 2000;361:1–6. [DOI] [PubMed] [Google Scholar]
  • 49.Fraser GE, Yan R, Butler TL, et al. Missing data in a long food frequency questionnaire: Are imputed zeroes correct? Epidemiology. 2009;202:289–294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Cattell RB. The scree test for the number of factors. Multivariate Behav Res. 1966;1:245–276. [DOI] [PubMed] [Google Scholar]
  • 51.Bryant FB, Yarnold PR. Chapter 4: principal-components analysis and exploratory and confirmatory factor analysis. In: Grimm LG, Yarnold PR, eds. Reading and Understanding Multivariate Statistics. 1st ed. Washington, DC: American Psychological Association; 1995:99–136. [Google Scholar]
  • 52.Stevens J. Applied Multivariate Statistics for the Social Sciences. Hillsdale, NJ: L. Erlbaum Associates; 1986. [Google Scholar]
  • 53.Kubo A, Levin TR, Block G, et al. Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol. 2008;1677:839–846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Kolahdooz F, Ibiebele TI, van der Pols JC, et al. Dietary patterns and ovarian cancer risk. Am J Clin Nutr. 2009;891:297–304. [DOI] [PubMed] [Google Scholar]
  • 55.Chan JM, Gong Z, Holly EA, et al. Dietary patterns and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Nutr Cancer. 2013;651:157–164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Jackson M, Tulloch-Reid M, Walker S, et al. Dietary patterns as predictors of prostate cancer in Jamaican men. Nutr Cancer. 2013;653:367–374. [DOI] [PubMed] [Google Scholar]
  • 57.Chang ET, Lee VS, Canchola AJ, et al. Dietary patterns and risk of ovarian cancer in the California Teachers Study cohort. Nutr Cancer. 2008;603:285–291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Sørensen LB, Raben A, Stender S, et al. Effect of sucrose on inflammatory markers in overweight humans. Am J Clin Nutr. 2005;822:421–427. [DOI] [PubMed] [Google Scholar]
  • 59.Juanola-Falgarona M, Salas-Salvadó J, Ibarrola-Jurado N, et al. Effect of the glycemic index of the diet on weight loss, modulation of satiety, inflammation, and other metabolic risk factors: a randomized controlled trial. Am J Clin Nutr. 2014;1001:27–35. [DOI] [PubMed] [Google Scholar]
  • 60.Hartman TJ, Albert PS, Zhang Z, et al. Consumption of a legume-enriched, low-glycemic index diet is associated with biomarkers of insulin resistance and inflammation among men at risk for colorectal cancer. J Nutr. 2010;1401:60–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Neuhouser ML, Schwarz Y, Wang C, et al. A low-glycemic load diet reduces serum C-reactive protein and modestly increases adiponectin in overweight and obese adults. J Nutr. 2012;1422:369–374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Wieland A, Kerbl R, Berghold A, et al. C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease. Med Pediatr Oncol. 2003;411:21–25. [DOI] [PubMed] [Google Scholar]
  • 63.Middleton B, Byers T, Marshall J, et al. Dietary vitamin A and cancer—a multisite case-control study. Nutr Cancer. 1986;82:107–116. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Web Material

Articles from American Journal of Epidemiology are provided here courtesy of Oxford University Press

RESOURCES